Bank Of New York Mellon Corp Alkermes Plc. Transaction History
Bank Of New York Mellon Corp
- $521 Trillion
- Q1 2024
A detailed history of Bank Of New York Mellon Corp transactions in Alkermes Plc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 2,882,411 shares of ALKS stock, worth $69.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,882,411
Previous 3,286,990
12.31%
Holding current value
$69.6 Million
Previous $91.2 Billion
14.43%
% of portfolio
0.01%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding ALKS
# of Institutions
356Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$704 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$487 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$360 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$217 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$201 Million0.03% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $3.97B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...